SCM
IMVT icon

Silverarc Capital Management’s Immunovant IMVT Stock Holding History

Silverarc Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3M Buy
+414,236
New +$10.7M 1.21% 26
2025
Q4 		– Sell
-50,000
Closed -$806K – 85
2025
Q3 		$806K Buy
+50,000
New +$809K 0.12% 70
2024
Q1 		– Sell
-20,000
Closed -$843K – 85
2023
Q4 		$843K Buy
+20,000
New +$736K 0.26% 60
2023
Q1 		– Sell
-519,614
Closed -$9.22M – 93
2022
Q4 		$9.22M Buy
519,614
+219,614
+73% +$2.77M 3.18% 9
2022
Q3 		$1.67M Buy
+300,000
New +$1.47M 0.71% 49
2021
Q2 		– Sell
-50,400
Closed -$808K – 107
2021
Q1 		$808K Sell
50,400
-49,600
-50% -$1.31M 0.45% 58
2020
Q4 		$4.62M Buy
+100,000
New +$4.62M 2.82% 10

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return